Bright Minds Biosciences (DRUG) Net Cash Flow (2019 - 2026)
Bright Minds Biosciences' Net Cash Flow came in at -$5.97 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $2.52 million a year earlier.
Bright Minds Biosciences (DRUG) Net Cash Flow (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bright Minds Biosciences reported Net Cash Flow of $171.82 million, up 326.4% year-over-year; for FY2025 (ended Sep 30, 2025), it was $55 million.
- Net Cash Flow carries a five-year compound annual growth rate of 124.5% (FY2020 to FY2025).
- Going back by fiscal year, Net Cash Flow was -$764,327 in FY2024, -$3.59 million in FY2023, $14.71 million in FY2022 (-44.3%) and $26.41 million in FY2021.
- The fiscal Q3 2026 figure represents the lowest quarterly Net Cash Flow since fiscal Q4 2023.
- The fastest year-over-year change in Net Cash Flow over five years came in fiscal Q2 2025 (growth of 217.9%), and the weakest in fiscal Q2 2022 (a decline of 86.0%).
- Business Quant data shows DRUG's Net Cash Flow at $159.86 million (Q2 2026), $5.43 million (Q1 2026) and $12.5 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Bright Minds Biosciences | 380.42 Mn | 380.42 Mn | - | -5.97 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97 Mn |
| Mar 31, 2026 | 159.86 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 38.32 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Jun 30, 2024 | -191,644.37 |
| Mar 31, 2024 | 581,172.60 |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | -9.60 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 3.62 Mn |
| Sep 30, 2022 | 5.52 Mn |
| Jun 30, 2022 | 2.25 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | 4.02 Mn |
| Sep 30, 2021 | 1.89 Mn |
Bright Minds Biosciences Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=DRUG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();